China has yet to leverage any formal penalties on GlaxoSmithKline for the $489 million bribery scandal that broke there last summer. But punishment may be on the way from GSK's home base.
GE Healthcare is readying space in Helsinki to host new startups, according to a report--a strategic way to tap into new technology as it continues to expand globally.
Merck KGaA went through a serious downsizing after its key multiple sclerosis drug candidate failed two years ago. But having rebounded faster than it expected, the German drugmaker is making some serious noise about being a more significant force.
Getting costs down on vaccines is always a big deal to countries like India, and so the government there is putting pressure on GlaxoSmithKline and Merck to give it a break on the human papillomavirus (HPV) vaccines, according to The New Indian Express.
Emerging markets have become more important for pharma, and that is no different for the companies that supply drugmakers. West Pharmaceutical Services, which makes packaging and delivery systems for sterile drug manufacturing, said international sales were a growth driver last year.
France's Acerde, which develops parts for X-ray tubes used in medical imaging, said it inked a development contract with an unnamed "China-based player " in the medical imaging space.
Novo Nordisk has its sights set on Mexico. The Danish drugmaker has put that country next on its list to debut liraglutide in its new guise as a weight-loss drug.
The Persian Gulf is the newest emerging market for Big Pharma, the Wall Street Journal reports. Drugmakers have jumped on that opportunity, as evidenced by the number of new plants and distribution facilities they are putting there.
Are the BRIC countries passé in Big Pharma? Not exactly. But multinational pharma's newest trend lies in the Persian Gulf, the Wall Street Journal reports.
Two of the biggest players in Brazil's medical diagnostics industry are likely to confront major changes in the coming months-- both worth noting as global competitors seek to enter one of the largest emerging markets around.